Clinical Trial Update: Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment [NA]

View source ↗

Summary

This study evaluates a chatbot to maximize hereditary cancer genetic risk assessment in individuals with gynecologic cancer or hereditary cancer syndrome. It is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer
• Hereditary Cancer Syndrome

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Gynecologic Cancer, Hereditary Cancer Syndrome | NA | Status: RECRUITING